[1-(naphthalen-1-yl)(2,2,2-2H3)ethyl]({3-[3-(trifluoromethyl)phenyl]propyl})amine hydrochloride

• ChemBase编号: 164764
• 分子式: C22H23ClF3N
• 平均质量: 393.8729296
• 单一同位素质量: 393.14711208
• SMILES: c12ccccc1cccc2C(NCCCc1cccc(c1)C(F)(F)F)C.Cl
• Canonical SMILES: CC(c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F.Cl
• InChI: InChI=1S/C22H22F3N.ClH/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25;/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3;1H
• InChIKey: QANQWUQOEJZMLL-UHFFFAOYSA-N

名称和登记号

名称

• IUPAC标准名: [1-(naphthalen-1-yl)(2,2,2-^2H₃)ethyl]({3-[3-(trifluoromethyl)phenyl]propyl})amine hydrochloride
• IUPAC传统名: [1-(naphthalen-1-yl)(2,2,2-^2H₃)ethyl]({3-[3-(trifluoromethyl)phenyl]propyl})amine hydrochloride
• 别名: α-(Methyl-d3)-N-[3-[3-(trifluoromethyl)phenyl)propyl]-1-napthalenemethanamine Hydrochloride; N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-(1-napthyl)ethylamine-d3 Hydrochloride; rac Cinacalcet-d3 Hydrochloride

登记号

• CAS号: 1185097-33-9
• PubChem SID: 162258899
• PubChem CID: 46781026

理论计算性质

• 质子受体: 1
• 质子供体: 1
• LogD (pH = 5.5): 3.042948
• LogD (pH = 7.4): 3.5335772
• Log P: 6.273198
• 摩尔折射率: 100.1173 cm^3
• 极化性: 38.956604 Å^3
• 极化表面积: 12.03 Å^2
• 可自由旋转的化学键: 7
• 里宾斯基五规则: false

分子性质

理化性质

• 溶解度: Ethanol; Methanol
• 外观: White to Off-White Solid
• 熔点: 111-113°C

安全信息

• 保存条件: -20°C Freezer

详细说明

Toronto Research Chemicals - C441802

Clinical trial in secondary hyperparathyroidism.

参考文献

• Franceschini N., et al.: Expert Opin. Invest. Drugs, 12, 1413 (2003)
• Block, G.A., et al.: N. Engl. J. Med. 350, 1516 (2003)